- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04583033
Sleep Well for Healthy Brain
November 29, 2023 updated by: Noam Alperin, University of Miami
Lifestyle Stressors of Hippocampus and Alzheimer's Disease (AD) Related Brain Regions: Potential for Intervention
The purpose of this study is to slow down the aging of the participant's brain by improving sleep quality.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Clara I. Morales
- Phone Number: 305-243-3404
- Email: c.morales1@miami.edu
Study Contact Backup
- Name: Sang Lee
- Phone Number: 305-243-6559
- Email: lsang2@miami.edu
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- English-speaking healthy subjects age 55 years and older capable and willing to consent to participate in the study. In addition, subject should be cognitively normal and have well documented sleep issues that results with poor sleep quality based on self-reported assessment.
Exclusion Criteria:
- pregnant women
- cognitively impaired subjects not able to provide consent
- prisoners
- Subjects 55 years of age and older that meet criteria for mild cognitive impairment.
- Subjects with any neurological disorder.
- Any other condition that in the opinion of the investigator may affect the participation in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Behavioral Therapy (CBT) Group
Participants will receive CBT intervention bi-weekly for total of six (6) sessions.
|
Treatment components include stimulus control, sleep restriction therapy, relaxation, and cognitive therapy.
Each session will last approximately one hour and will be provided on line.
|
No Intervention: Control Group
Participants will not receive any intervention as part of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of brain tissue volume loss in specific brain regions
Time Frame: Year 2
|
As evaluated from the Magnetic Resonance Imaging (MRI) Brain scan
|
Year 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive Performance
Time Frame: Year 2
|
Cognitive performance will be assessed using a Memory test which has a composite score ranging from 80 to 120 % with a higher score indicating better performance and a midrange at 100%.
|
Year 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Noam Alperin, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 28, 2021
Primary Completion (Actual)
October 31, 2023
Study Completion (Actual)
October 31, 2023
Study Registration Dates
First Submitted
October 6, 2020
First Submitted That Met QC Criteria
October 6, 2020
First Posted (Actual)
October 12, 2020
Study Record Updates
Last Update Posted (Estimated)
December 1, 2023
Last Update Submitted That Met QC Criteria
November 29, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 20201031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Poor Quality Sleep
-
University GhentEuropean CommissionEnrolling by invitation
-
Wecare Probiotics Co., Ltd.Recruiting
-
Cerebra MedicalEkosi Health CentreRecruiting
-
National Taiwan University HospitalCompleted
-
University of SaskatchewanCompleted
-
Columbia UniversityCompletedPoor Quality SleepUnited States
-
Dr. Zannatun Nahar NuriCompletedPoor Sleep QualityBangladesh
-
Emory UniversitySunovionCompletedPoor Quality Sleep
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
Clinical Trials on Cognitive Behavioral Therapy (CBT)
-
University of California, Los AngelesNational Institute of Nursing Research (NINR)Completed
-
Emory UniversityAlzheimer's AssociationCompleted
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
The University of Texas Health Science Center at...59th Medical Wing; Brooke Army Medical Center; South Texas Veterans Health Care...CompletedCombat Disorders | Post-Traumatic Stress Disorders | Stress DisordersUnited States
-
Massachusetts General HospitalActive, not recruitingDepression | Obsessive Compulsive Disorder | Generalized Anxiety Disorder | Attention Deficit Hyperactivity Disorder | Trichotillomania | Panic Disorder | Social Phobia | Specific Phobia | Tourette Syndrome | Post-Traumatic Stress Disorder | Body Dysmorphic Disorder | Eating Disorder | General Medical ConditionUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedSomatoform Disorders | Body Dysmorphic DisorderUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDepression | Traumatic Brain InjuryUnited States
-
University of FloridaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
VA Connecticut Healthcare SystemUnited States Department of DefenseRecruitingBinge-Eating Disorder | Bulimia Nervosa | Cognitive Behavioral Therapy | Veterans HealthUnited States
-
University of California, Los AngelesRecruitingMood Disorders | AdolescentsUnited States